Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
2016 ◽
Vol 15
(4)
◽
pp. 382-390
◽
Keyword(s):
Phase 2
◽
2014 ◽
Vol 13
(11)
◽
pp. 1100-1107
◽